BAJAJ BROKING

Notification close image
No new Notification messages
card image
Seshaasai Technologies Ltd IPO
Apply for the Seshaasai Technologies Ltd IPO through UPI in Just minutes
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

0

530697

ZENLABS

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

Zenlabs Ethica Limited Share Price Update

As of the latest trading session, Zenlabs Ethica Limited share price is currently at ₹ 31.9, which is up by ₹ 2.08 from its previous closing. Today, the stock has fluctuated between ₹ 31.90 and ₹ 32.90. Over the past year, Zenlabs Ethica Limited has achieved a return of -27.40 %. In the last month alone, the return has been -6.81 %. Read More...

Investment Returns

Over 1 Month [-]% Over 3 Months [-]% Over 6 Months [-]% Over 1 Year [-]%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

Zenlabs Ethica Limited fundamentals


  • Market cap (Cr)

    [-]

  • P/E Ratio (TTM)

    [-]

  • Beta

    [-]

  • Book Value / share

    [-]

  • Return on equity

    [-]%

  • EPS (TTM)

    [-]

  • Dividend yield

    [-]%

  • Net profit/quarter (Cr)

    [-]

info icon alternate text
  • Market cap (Cr)

    20.80

  • P/E Ratio (TTM)

    74.55

  • Beta

    0.73

  • Book Value / share

    16.01

  • Return on equity

    2.63%

  • EPS (TTM)

    0.40

  • Dividend yield

    [-]%

  • Net profit/quarter (Cr)

    0.03

info icon alternate text

Zenlabs Ethica Limited Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars JUN 2025 (Values in Cr)
Revenue 11.48
Operating Expense 11.44
Net Profit 0.03
Net Profit Margin (%) 0.26
Earnings Per Share (EPS) 0.05
EBITDA 0.54
Effective Tax Rate (%) 25.00
Particulars MAR 2025 (Values in Cr)
Revenue 12.99
Operating Expense 12.87
Net Profit 0.09
Net Profit Margin (%) 0.69
Earnings Per Share (EPS) 0.14
EBITDA 0.70
Effective Tax Rate (%) 37.50
Particulars DEC 2024 (Values in Cr)
Revenue 12.72
Operating Expense 12.60
Net Profit 0.09
Net Profit Margin (%) 0.70
Earnings Per Share (EPS) 0.13
EBITDA 0.69
Effective Tax Rate (%) 30.76
Particulars SEP 2024 (Values in Cr)
Revenue 13.35
Operating Expense 13.28
Net Profit 0.05
Net Profit Margin (%) 0.37
Earnings Per Share (EPS) 0.08
EBITDA 0.62
Effective Tax Rate (%) 25.00
Particulars JUN 2024 (Values in Cr)
Revenue 12.36
Operating Expense 12.30
Net Profit 0.04
Net Profit Margin (%) 0.32
Earnings Per Share (EPS) 0.06
EBITDA 0.62
Effective Tax Rate (%) 42.85
Particulars MAR 2025 (Values in Cr)
Revenue 51.42
Operating Expense 51.05
Net Profit 0.27
Net Profit Margin (%) 0.52
Earnings Per Share (EPS) 0.41
EBITDA 2.62
Effective Tax Rate (%) 37.20
Particulars MAR 2024 (Values in Cr)
Revenue 58.56
Operating Expense 58.28
Net Profit 0.42
Net Profit Margin (%) 0.71
Earnings Per Share (EPS) 0.65
EBITDA 2.70
Effective Tax Rate (%) 27.58
Particulars MAR 2023 (Values in Cr)
Revenue 66.89
Operating Expense 65.76
Net Profit 0.49
Net Profit Margin (%) 0.73
Earnings Per Share (EPS) 0.75
EBITDA 2.45
Effective Tax Rate (%) 28.35
Particulars MAR 2022 (Values in Cr)
Revenue 69.09
Operating Expense 67.91
Net Profit 0.82
Net Profit Margin (%) 1.18
Earnings Per Share (EPS) 1.26
EBITDA 2.52
Effective Tax Rate (%) 34.92
Particulars MAR 2021 (Values in Cr)
Revenue 56.64
Operating Expense 55.83
Net Profit 0.83
Net Profit Margin (%) 1.46
Earnings Per Share (EPS) 1.41
EBITDA 1.23
Effective Tax Rate (%) 9.78
Particulars MAR 2025 (Values in Cr)
Book Value / Share 16.01
ROE % 2.63
ROCE % 5.32
Total Debt to Total Equity 1.34
EBITDA Margin 5.10
Particulars MAR 2024 (Values in Cr)
Book Value / Share 15.55
ROE % 4.24
ROCE % 6.51
Total Debt to Total Equity 1.04
EBITDA Margin 4.63
Particulars MAR 2023 (Values in Cr)
Book Value / Share 14.91
ROE % 9.46
ROCE % 11.42
Total Debt to Total Equity 0.51
EBITDA Margin 4.53
Particulars MAR 2022 (Values in Cr)
Book Value / Share 14.34
ROE % 8.72
ROCE % 12.25
Total Debt to Total Equity 0.36
EBITDA Margin 3.59
Particulars MAR 2021 (Values in Cr)
Book Value / Share 13.16
ROE % 9.64
ROCE % 11.52
Total Debt to Total Equity 0.21
EBITDA Margin 3.28
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 1.79
Total Assets 40.62
Total Liabilities 40.62
Total Equity 10.42
Share Outstanding 6510015
Price to Book Ratio 1.95
Return on Assets (%) 0.66
Return on Capital (%) 1.21
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.92
Total Assets 40.25
Total Liabilities 40.25
Total Equity 10.12
Share Outstanding 6510015
Price to Book Ratio 2.67
Return on Assets (%) 1.04
Return on Capital (%) 1.82
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 1.63
Total Assets 43.49
Total Liabilities 43.49
Total Equity 9.70
Share Outstanding 6510015
Price to Book Ratio 4.63
Return on Assets (%) 1.12
Return on Capital (%) 3.86
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 1.50
Total Assets 37.89
Total Liabilities 37.89
Total Equity 9.33
Share Outstanding 6510015
Price to Book Ratio 1.99
Return on Assets (%) 2.06
Return on Capital (%) 7.31
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 1.69
Total Assets 32.20
Total Liabilities 32.20
Total Equity 8.56
Share Outstanding 6510015
Price to Book Ratio 1.61
Return on Assets (%) 2.38
Return on Capital (%) 8.58
Particulars MAR 2025 (Values in Cr)
Net Income 0.42
Cash from Operations 4.04
Cash from Investing 0.13
Cash from Financing -3.08
Net change in Cash 0.88
Free Cash Flow 4.06
Particulars MAR 2024 (Values in Cr)
Net Income 0.58
Cash from Operations -8.93
Cash from Investing 0.10
Cash from Financing 8.23
Net change in Cash -0.71
Free Cash Flow -8.90
Particulars MAR 2023 (Values in Cr)
Net Income 0.67
Cash from Operations 1.78
Cash from Investing -1.46
Cash from Financing 0.06
Net change in Cash 0.11
Free Cash Flow 3.33
Particulars MAR 2022 (Values in Cr)
Net Income 1.22
Cash from Operations -0.25
Cash from Investing 0.00
Cash from Financing 0.31
Net change in Cash -0.06
Free Cash Flow -0.23
Particulars MAR 2021 (Values in Cr)
Net Income 0.86
Cash from Operations -8.31
Cash from Investing 0.15
Cash from Financing -0.52
Net change in Cash -8.78
Free Cash Flow -8.31
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 31.98 13.05 1.75 245.07 30.00 / 68.00
BLISS GVS PHARMA LTD 152.20 15.08 1.53 1607.98 105.05 / 190.65
CIPLA LTD 1577.80 23.63 4.08 127449.27 1310.05 / 1611.10
FERMENTA BIOTECH LIMITED 263.45 7.42 2.13 775.36 219.00 / 449.00
GLAXOSMITHKLINE PHARMA LT 2741.35 49.04 23.79 46440.12 1924.30 / 3515.95
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 31.98 17.38 5.05 245.07 30.00 / 68.00
AMRUTAJAN HEALTH LTD 719.25 38.14 6.36 2079.40 548.05 / 829.00
ASTRAZENECA PHARMA IND LT 9160.95 108.30 29.72 22902.38 6222.35 / 10653.05
BLISS GVS PHARMA LTD 152.20 22.78 1.51 1607.98 105.05 / 190.65

Zenlabs Ethica Limited shareholding pattern

Holding

Others
47.03%
Promoter Holdings
52.96%
FII
0.0%
DII
0.0%
Promoter Shares(Pledge Percentage)
0.0%
Name Shares Category
Preet Remedies Limited 1730455.0 (26.58%) Shareholding of Promoter and Promoter Group
Sanjay Dhir 857728.0 (13.18%) Shareholding of Promoter and Promoter Group
Sanjeev Kumar Singal 857574.0 (13.17%) Shareholding of Promoter and Promoter Group
Hitesh Popatlal Oswal 441962.0 (6.79%) Public Shareholding
B S Mallikarjuna 139385.0 (2.14%) Public Shareholding
Bhasakarrai Kanyalal Bhatt 120945.0 (1.86%) Public Shareholding
Shyama Goyal 82297.0 (1.26%) Public Shareholding
Harjinder Kaur 1000.0 (0.02%) Shareholding of Promoter and Promoter Group
Himjyoti 1000.0 (0.02%) Shareholding of Promoter and Promoter Group
Daman Singhal 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Kulwant Kaur 0.0 (0.0%) Shareholding of Promoter and Promoter Group

Transparent Pricing and 360° Services

Choose a Plan That Suits Your Goals and Needs

greenshadow greenshadow redshadow pricing-pack Freedom Pack
₹20/order 14.99% p.a. MTF
tick Stock Picks by Research Analysts tick Seamless Onboarding

Subscription Charge : FREE

greenshadow greenshadow redshadow pricing-pack

Professional Pack

₹10/order 11.99% p.a. MTF
tick Stock Picks by Research Analysts tick Seamless Onboarding

Subscription Charge : ₹2,500 Yearly

50% Brokerage Savings
greenshadow greenshadow redshadow pricing-pack

Signature

0.2% on Delivery 11.99% p.a. MTF
tick Dedicated Relationship Manager tick Customised Brokerage Support tick Stock Picks by Research Analysts tick Experienced Dealer Support

News

Left Arrow
Right Arrow

Zenlabs Ethica Limited Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
31.98 7.24 redarrow
red-green-graph indicator
0 Bearish
16 Bullish
  • 5 Days 30.30
  • 26 Days 31.10
  • 10 Days 30.50
  • 50 Days 31.60
  • 12 Days 30.60
  • 100 Days 32.30
  • 20 Days 30.90
  • 200 Days 33.80
30.46 PIVOT

First Support

29.21

First Resistance

31.81

Second Support

27.86

Second Resistance

33.06

Third Support

26.61

Third Resistance

34.41

RSI

43.87

ADX

14.93

MACD

-0.48

Williams % R

-66.79

Commodity Channel Index (CCI)

-79.27

Date

2025-10-17

Week

784.00

Same Day

1066.00

Month

1833.00

1 Year

0.75

3 Year

0.63

Over 1 Month

-6.81%

down

Over 1 Year

-27.40%

down

Over 3 Months

-14.31%

down

Over 3 Years

-26.80%

down

Over 6 Months

-4.60%

down

Over 5 Years

5.19%

down

Zenlabs Ethica Limited Corporate Actions

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]
Dividend date Dividend amount Dividend type Record date Instrument type
29 Jul 2022 0.25 Interim 01 Aug 2022 Equity shares
20 Sep 2017 0.25 Final 22 Sep 2017 Equity shares
Ex-Date Ex-Bonus Ratio
13 Oct 2018 11 Oct 2018 1:20
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]

Zenlabs Ethica Limited Share Price

Zenlabs Ethica Limited (Formerly known Neelkanth Technologies Limited) was incorporated in 1993. The Company is one of the top 10 pharmaceutical contract marketing and trading companies in India that markets and distribute a wide range of branded drugs including Gastrointestinal disorders, Anti-Diabetics, Anti-Hypertensive Drugs, Anti-Infective, Soaps & Anti-Bacterial Drugs, Nutraceuticals, etc., It boasts of a comprehensive global network. It deals into marketing and distribution of pharmaceutical products and has grown to be of India's top pharmaceutical companies in 2019.

The Company has been launched in collaboration with Zenlabs Pharmaceutical Inc, Canada. The strength lies in quality, affordable and branded drugs in enhancing the quality of life of people. Apart from this, it offers more than 600 products across therapeutic segments, making it a leader among pharmaceutical companies in India.

In 2023, the Company has ventured into diversified segments like Neurology and Cytrics. It manufactures drugs for varied brands and sticks to international standards and prescribed norms. These drugs are marketed in factory packaging. As a WHO GMP certified company, the quality of each product is of highly advanced procurement & supply facility.

Parent organization Indian Private
NSE symbol [-]
Founded 1993
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Zenlabs Ethica Ltd?

Answer Field

Zenlabs Ethica Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 31.98 as on Oct 20 2025 01:15 PM.

What is the Market Cap of Zenlabs Ethica Ltd Share?

Answer Field

The market cap of Zenlabs Ethica Ltd for NSE ₹ 0.00 & for BSE ₹ 20.80 as on Oct 20 2025 01:15 PM.

What is the 52 Week High and Low of Zenlabs Ethica Ltd?

Answer Field

The 52 Week High and Low of Zenlabs Ethica Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 46.89 and ₹ 27.33.

What is 1 year return for Zenlabs Ethica Ltd?

Answer Field

The 1 year returns on the stock has been -27.40%.

What is the P/E Ratio of Zenlabs Ethica Ltd Share?

Answer Field

As on Oct 20 2025 01:15 PM the price-to-earnings (PE) ratio for Zenlabs Ethica Ltd share is 74.55.

What is the PB ratio of Zenlabs Ethica Ltd Share?

Answer Field

As on Oct 20 2025 01:15 PM, the price-to-book (PB) ratio for Zenlabs Ethica Ltd share is 16.01.

How to Buy Zenlabs Ethica Ltd Share?

Answer Field

You can trade in Zenlabs Ethica Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Zenlabs Ethica Ltd Share on Bajaj Broking App?

Answer Field

To buy Zenlabs Ethica Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Zenlabs Ethica Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59